managedlab.com
Elanco Bolsters Pet Products Pipeline With $234M Deal for Aratana
Drugs that treat dogs and cats are some of Elanco’s fastest growing products, and the animal health company is poised to make that category even bigger through a deal to buy pet medicines developer Aratana